alternatives to glp 1 agonists New research from @doctorsigh shows that stopping GLP-1 medications doesn't have mean losing progress. The study compared three next-step strategies after discontinuing treatment: lifestyle changes, switching medications, or endoscopic gastric Switching between GLP‐1 receptor agonists

Eli Lilly says full data from its latest Phase 3 trial will be published in a peer-reviewed journal at a future date.

Blocking this pathway could be a promising therapeutic strategy for DPN by curbing the inflammatory response and potentially preventing further nerve damage [76]

Based on current evidence, GLP-1RAs are not recommended as first-line therapy for type 2 diabetic patients at high risk for colorectal cancer [47]

Neuroprotective Effects of the Novel GLP-1 Long Acting Analogue Semaglutide in the MPTP Parkinsons Disease Mouse Model

23 Rapid weight loss after gastric bypass, biliopancreatic diversion or sleeve gastrectomy has been reported to initiate gallstone formation in 30% of patients during the first six to 12 months after surgery

Notable Recent Developments Introduction of Novel GLP-1 Receptor Agonists: Pharmaceutical companies have launched new GLP-1 receptor agonists with improved delivery mechanisms, diversifying the treatment options available